Showing results (401-410 of 472) with videos related to
Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|July 30, 2009
Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA studyHidehiko Hara, Masato Nakamura, Itaru Yokouchi, et al.Therapeutic Advances in Cardiovascular Disease|September 4, 2009
Clinical pharmacology of antithrombotic drugs in coronary artery diseaseJoachim FaulerTherapeutic Advances in Cardiovascular Disease|May 20, 2009
Retinal changes and cardiac remodelling in systemic hypertensionCesare Cuspidi, Francesca Negri, Valentina Giudici, et al.Therapeutic Advances in Cardiovascular Disease|June 25, 2010
Contemporary practices in postcardiac arrest syndrome: the role of mild therapeutic hypothermiaGerasimos Gavrielatos, Klaus Dieter Werner, Eftichios Voridis, et al.Therapeutic Advances in Cardiovascular Disease|August 11, 2010
Evaluation of left ventricular hypertrophy in patients requiring permanent pacingAlexandros Alexopoulos, Anastasia Perpinia, Nikolaos Michelakakis, et al.Therapeutic Advances in Cardiovascular Disease|April 20, 2010
The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular diseaseMark C HoustonTherapeutic Advances in Cardiovascular Disease|May 23, 2009
The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular diseaseRichard KonesTherapeutic Advances in Cardiovascular Disease|May 26, 2009
The comparison of early and late outcome of direct and conventional stenting of patients with st elevation myocardial infarctionGulten Tacoy, Guliz Erdem Yazici, Murat Erden, et al.Therapeutic Advances in Cardiovascular Disease|June 4, 2009
Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysisHiromichi SuzukiTherapeutic Advances in Cardiovascular Disease|June 18, 2009
Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis ratJewell A Jessup, Brian M Westwood, Mark C Chappell, et al.Pageof 48